Position in ERAS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$49,444,412
+$43,448,332 QoQ
Shares Held
3,055,897
+89.6% QoQ
Ownership
0.983%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 94.48076947619634.ToString("F0")%
Shared 0.ToString("F0")%
None 5.519230523803649.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Sep 30, 2022CallValue
$15,600
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. ERAS ranks #45 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,444,412 | 3,055,897 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,996,080 | 1,611,850 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,344,715 | 1,534,274 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,995,582 | 1,571,325 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,669,889 | 1,948,825 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,883,890 | 1,945,773 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,522,430 | 4,220,671 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,063,234 | 1,721,710 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,531,157 | 2,199,591 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,547,978 | 726,751 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,064,421 | 540,316 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,711,563 | 620,132 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,959,314 | 2,976,517 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,560,867 | 2,682,336 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $15,600 | 2,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $668,669 | 85,727 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,328 | 15,499 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $119,315 | 13,874 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $149,162 | 9,574 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $248,804 | 11,725 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||